Baseline cohort characteristics and nonfasting lipid panel
| Variable | Mean ± SD or no. (%) | Standardized difference | ||
|---|---|---|---|---|
| Total n = 13 988 | Without incident CVD n = 12 832 | With incident CVD n = 1156 | ||
| Age, yr | 61.8 ± 9.7 | 61.2 ± 9.6 | 68.1 ± 8.6 | −0.76 |
| Sex, female | 9710 (69.4) | 9040 (70.5) | 670 (58.0) | 0.26 |
| Statin use | 2639 (18.9) | 2342 (18.3) | 297 (25.7) | 0.18 |
| Elixhauser Comorbidity Index score | 2.80 ± 2.19 | 2.83 ± 2.19 | 2.52 ± 2.17 | 0.14 |
| LDL cholesterol, mmol/L | 2.86 ± 0.85 | 2.88 ± 0.84 | 2.69 ± 0.93 | 0.21 |
| HDL cholesterol, mmol/L | 1.51 ± 0.44 | 1.52 ± 0.45 | 1.39 ± 0.42 | 0.29 |
| Total cholesterol, mmol/L | 5.15 ± 0.96 | 5.17 ± 0.95 | 4.95 ± 1.06 | 0.22 |
| Non-HDL cholesterol, mmol/L | 3.65 ± 0.95 | 3.66 ± 0.94 | 3.56 ± 1.01 | 0.10 |
| Remnant cholesterol, mmol/L | 0.78 ± 0.38 | 0.78 ± 0.38 | 0.87 ± 0.40 | −0.24 |
| Triglycerides, mmol/L | 1.73 ± 0.84 | 1.71 ± 0.84 | 1.92 ± 0.88 | −0.25 |
Note: CVD = cardiovascular disease, HDL = high-density lipoprotein, LDL = low-density lipoprotein, SD = standard deviation.